USP13 Antibody

Western blot: 1:500-1:1000, Immunohistochemistry (FFPE): 1:50-1:100

The stated application concentrations are suggested starting points. Titration of the USP13 antibody may be required due to differences in protocols and secondary/substrate sensitivity.

Modification of target proteins by ubiquitin participates in a wide array of biological functions. Proteins destined for degradation or processing via the 26 S proteasome are coupled to multiple copies of ubiquitin. However, attachment of ubiquitin or ubiquitin-related molecules may also result in changes in subcellular distribution or modification of protein activity. An additional level of ubiquitin regulation, deubiquitination, is catalyzed by proteases called deubiquitinating enzymes, which fall into four distinct families. Ubiquitin C-terminal hydrolases, ubiquitin-specific processing proteases (USPs),1 OTU-domain ubiquitin-aldehyde-binding proteins, and Jab1/Pad1/MPN-domain-containing metallo-enzymes. Among these four families, USPs represent the most widespread and represented deubiquitinating enzymes across evolution. USPs tend to release ubiquitin from a conjugated protein. They display similar catalytic domains containing conserved Cys and His boxes but divergent N-terminal and occasionally C-terminal extensions, which are thought to function in substrate recognition, subcellular localization, and protein-protein interactions.

Purified

In 1X PBS, pH 7.4, with 0.09% sodium azide

A portion of amino acids 389-419 from the human protein was used as the immunogen for the USP13 antibody.

This USP13 antibody is available for research use only.

Cytoplasmic, nuclear

Purified

Human, Mouse

Q92995